Olmesartan Price in Washington
Compare cash-pay prices for Olmesartan (Olmesartan Medoxomil) from verified pharmacies across Washington. No insurance required.
Washington Median
$17
per month
National Average
$45
per month
Your Savings
62%
below national avg
Pharmacies in Top Washington Cities
Progressive pharmacy market with strong price competition, especially in the Seattle metro.
Seattle
Olmesartan pharmacies
Spokane
Olmesartan pharmacies
Tacoma
Olmesartan pharmacies
Vancouver
Olmesartan pharmacies
Bellevue
Olmesartan pharmacies
Olmesartan in Washington: Frequently Asked Questions
How much does Olmesartan cost in Washington?
The median cash-pay price for Olmesartan in Washington is approximately $17. Prices range from $14 to $24 depending on the pharmacy, dosage, and quantity. This is 62% below the national average of $45.
Do I need insurance to buy Olmesartan in Washington?
No. You can purchase Olmesartan at cash-pay prices from any licensed pharmacy in Washington without insurance. Script Unlock helps you compare cash-pay bids from verified pharmacies to find the lowest price.
Which pharmacies in Washington offer the best Olmesartan prices?
Prices vary significantly between pharmacies. Independent pharmacies and compounding pharmacies in Seattle and Spokane often offer competitive cash-pay pricing. Upload your prescription to Script Unlock to compare live bids from verified Washington pharmacies.
Can I get Olmesartan delivered in Washington?
Yes. Many pharmacies in Washington offer mail-order delivery for Olmesartan. Some pharmacies also offer free local delivery in metro areas like Seattle. Check with each pharmacy when comparing bids on Script Unlock.
Are there generic alternatives to Olmesartan available in Washington?
Yes, the generic version (Olmesartan Medoxomil) is available at most Washington pharmacies and is typically 50-80% cheaper than the brand name. Washington state has a Prescription Drug Affordability Board reviewing high-cost medications.
Washington Pharmacy Regulation: Washington state has a Prescription Drug Affordability Board reviewing high-cost medications.